Overvalued stock on all metrics. When market turns down, this will fall below $80 in a flash. With maturation of their business model in 98% of US locations, where do you think this is headed? Long-term growth is gone .. maybe 5% year over year with 1 or 2 10% years if they are lucky. $6 - $8 earnings year-over-year, 8 - 10 multiple ... stock will be fairly valued between $48 and $80 a share.
This is a good value, but not as stellar as you believe until silver prices are at $18 and up. Then you will start to see earnings of several pennies a share per quarter. But $3 share price won't likely happen until silver is over $20 oz.
Their are management and administrative costs which require silver to be at $14 to break even. You are only including all-in mining costs.
Long term value here. But earnings and report are not stellar enough to warrant buying at these prices without an increase to the silver price. This will fall back to the mid 1.20's unless silver heads over $18 quickly. Remember silver could drop back to 15-16 range before the next leg up, and that will send this stock back to $1 - $1.10 range. I am not recommending to sell here but i would make sure to have enough buying power to pick up some shares on the retracement.
This is a no brainer ... drug potential is huge, phase 3 will be already underway. Company has a lot of cash. This is not where you sell, this is where you buy and look the other way. Pay no attention to the share price and buy hand over fist under $5. I would still call this a buy under $7. But what do I know? All I know at under $4 this is a steal. Corruption at it's best. They will steal every share possible from retail investors. If you are reading this and thinking about selling CLDX, you shouldn't be in the market because you don't have a clue on what you are doing.
Sentiment: Strong Buy
That should be the headline. Corrupt Wall street hedge funds at it again with another group of analysts whose pockets are lined to follow the easy money. Disgusting. What will happen next is they will buy in in the 26 - 28 range, then there will be an earnings surprise and stock will jump to 35+ again. The banks should not be allowed to have analysts put public price targets on stocks. That is how they manipulate the markets. This rule should be passed by Congress. Only analysts not affiliated with banks, like true research firms, should be able to disclose price targets to the public.
Sentiment: Strong Buy
You think? You think in a market that is going up that a company worth close to $3 a share in cash and no debt trading at 50 percent of its cash and partnered with a pharma giant will go lower? Good luck with that theory as it goes to the $1.70's next week on zero news and $2 in May, again on no news. Hopefully there will be news and it will just go into the $3's so we can then watch it trade on cash value and get the pipeline for free. There are no bagholders here only people like you trying to convince people it will go lower. Your posing is a waste of reading time and next #$%$ post I see from you lands you on th ignore list.
It's quite obvious the company involved in trying to get KBIO out of bankruptcy was simply using this as a tactic to get the share price to spike up and sell out. I don't see any reason to validate the buyout of this company. None. It angers me that people fall for this nonsense and our government just lets hedge funds get away with this activity. It's pitiful. Keep playing the game and making others suffer. If you are fearful of getting underwater, just partner with a hedgefund and they will bail you out. If you don't friends at the hedgefund, just make sure you don't get involved on the wrong side of the trade. Hedgefunds are why America sucks. Until they throw some of these guys in jail, the rules for hedgefunds will always be different for everyone else. Tax evasion and insider trading are just some of the things people in Congress get away with. Hedgefunds are in bed with them - don't kid yourself.
Even if it were to double, that isn't reason to get bent up about big guys holding down the stock price. Unless I saw like 5 million short, then I might have agreed there could be one or two big players holding down the price. So your argument that the stock price is being held down by the short positions of some big players holds little to no water. Anything under 5 percent short is no reason to think that insidious forces are at work. No doubt people are playing around here, but nothing that alarms me or makes me think someone is gong to drive this down to 85 cents. That only will happen if the biotech sector were to erode further. From the looks of things, biotechs will rebounds another 20 percent or more from here before the market either goes up another major leg or retests the recent bottom.
You have to look at the actual numbers, not what happens on a daily basis because it doesn't reflect the accumulated short positions. People short and buy back throughout the day ... I get it. Someone is making a nice profit doing this. Probably accumulating shares with the profits . But NASDAQ is providing accurate short interest. So, again, until an accumulated number comes out which will probably be in the next business day or two, you need to stop spreading false stats to people. Like I said, less than 2 percent of the float is short.
You made this #$%$ up. Do you know the short interest in under 2 percent of the float? Why make this up? 620,000 shares short - if you call major players involved in this data, then data analysis is just not your thing.
It will be between .95 and 1.05 most likely. .85 and 1.25 are wishful thinking. Maybe Shrekeli will make a move and buy out the company for $100 million this month.
It is but people are looking for fast movers and this will sit in the 95 cent to 1.20 range most likely for the next 3 months. It wouldn't shock me if the range was tighter, say .95 to 1.05.
We probably will trade in the 95 cent to 1.20 range until news. I think a positive subgroup will send this to $2 to $2.50. I'm not confident we'll get any huge spikes beyond that this year unless a partner is announced.
in May. At some point, this will probably fall into low 30s. Most likely 20 for 1, so it will open around $6 and fall into the $4 to $5 range. That means that shares worth 40 cents today will be worth 25 cents after the RS. Hence why you didn't see the spike last very long on the news.